Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis-Reference-Cited by-同舟云学术

Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis

Published:2005-02 Issue:2 Volume:58 Page:171-174
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Andrade Susan E.,Graham David J.,Staffa Judy A.,Schech Stephanie D.,Shatin Deborah,La Grenade Lois,Goodman Michael J.,Platt Richard,Gurwitz Jerry H.,Chan K. Arnold

Publisher

Elsevier BV

Subject

Epidemiology

Reference7 articles.

1. Statin-associated myopathy;Thompson;JAMA,2003

2. Lipid-lowering agents and myopathy;Wormann;Curr Opin Rheumatol,2002

3. Risk for myopathy with statin therapy in high-risk patients;Ballantyen;Arch Intern Med,2003

4. Cerivastatin and reports of fatal rhabdomyolysis;Staffa;N Engl J Med,2002

5. HMG-CoA reductase inhibitors and myotoxicity;Ucar;Drug Safety,2000

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of diagnosis codes in healthcare databases in Taiwan, a literature review;Pharmacoepidemiology and Drug Safety;2023-03-27

2. Effect of SLCO1B1 T521C on Statin‐Related Myotoxicity With Use of Lovastatin and Atorvastatin;Clinical Pharmacology & Therapeutics;2021-07-23

3. Risk factors and future directions for preventing and diagnosing exertional rhabdomyolysis;Neuromuscular Disorders;2021-07

4. Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study;Journal of Atherosclerosis and Thrombosis;2021

5. A Case‐Crossover–Based Screening Approach to Identifying Clinically Relevant Drug–Drug Interactions in Electronic Healthcare Data;Clinical Pharmacology & Therapeutics;2019-03-18